![]() |
市場調查報告書
商品編碼
1938331
行動式C臂市場 - 全球產業規模、佔有率、趨勢、機會及預測(按類型、技術、應用、最終用戶、地區和競爭格局分類),2021-2031年Mobile C-Arm Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, By End Users, By Region & Competition, 2021-2031F |
||||||
全球移動式 C 型臂市場預計將從 2025 年的 19.8 億美元成長到 2031 年的 27.5 億美元,複合年成長率為 5.63%。
這些多功能診斷影像設備在手術室中至關重要,可在心血管、整形外科和創傷手術中提供即時透視影像。其成長主要受以下因素驅動:全球慢性疾病負擔日益加重,需要手術治療;人口老化;以及微創手術(需要術中引導)的顯著增加。英國國家醫療服務體系 (NHS) 2024 年的數據也印證了這項需求,數據顯示,診斷影像檢查的數量將達到 4,720 萬例(比上一年成長 4.8%),其中透視手術量將增加 2.0%。這凸顯了行動診斷影像設備對於提高手術精準度和改善病患預後的重要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 19.8億美元 |
| 市場規模:2031年 | 27.5億美元 |
| 複合年成長率:2026-2031年 | 5.63% |
| 成長最快的細分市場 | 平板 |
| 最大的市場 | 北美洲 |
然而,由於先進系統需要大量資本投資,而醫療機構預算緊張,市場成長面臨許多障礙。高昂的實施和維護成本往往迫使小規模的醫療機構推遲設備升級,從而限制了最新技術的應用。此外,現有硬體的耐用性導致更換週期長,阻礙了市場快速滲透,儘管高階移動式C臂機具有明顯的臨床重要性,但製造商仍難以證明其投資回報率。
慢性病和整形外科疾病發生率的上升是全球移動式C臂市場的主要驅動力。隨著人口老化,骨質疏鬆症和骨關節炎等與老齡化相關的疾病導致手術數量增加,尤其是骨折修復和關節重建。移動式C臂對於這些手術至關重要,因為它們可以提供高解析度的即時影像,從而實現精準的植入定位並降低再次手術率。美國關節重建註冊中心於2025年10月發布的《2025年度報告》也印證了這一成長趨勢,該報告指出,髖關節和膝關節關節重建手術的累積數量將超過440萬例,比上一年成長8.8%。這表明,人們越來越依賴行動成像設備來應對肌肉骨骼疾病帶來的負擔。
同時,全球對微創手術 (MIS) 技術日益成長的需求正在改變市場動態。醫療服務提供者越來越注重能夠減輕患者不適、縮短恢復時間的手術,並高度依賴移動式 C 型臂提供的先進透視引導技術,尤其是在脊柱和介入心臟病學等對精準度要求極高的手術中。西門子醫療於 2025 年 11 月發布的 2025 會計年度第四季度財務業績反映了對介入設備的強勁需求,數據顯示,該公司先進療法部門的收入同比成長 3.8%。此外,通用電氣醫療集團 2025 年 10 月的報告顯示,由於診斷影像業務的強勁表現,其第三季總收入成長了 6%,這表明隨著醫療機構不斷提升診斷能力以適應複雜的工作流程,市場成長勢頭將持續強勁。
全球移動式C臂市場面臨一個重大障礙:先進診斷影像設備的高昂購置成本,而醫療機構預算緊張加劇了這個問題。門診中心和醫院通常財務狀況拮据,迫使管理者仔細評估每一筆資本支出。購置和維護設備的高成本阻礙了醫療機構更換老舊設備的意願,導致老舊硬體長期使用。這種財務上的謹慎態度抑制了標準的更新換代週期,並成為市場成長的瓶頸,因為資金短缺延緩了採用新型、臨床性能更優的移動式C臂系統進行複雜手術的進程。
近期產業統計也印證了這種投資延遲的趨勢,這些數據凸顯了財務壓力的嚴峻性。根據美國醫院協會 (AHA) 2025 年的數據,約 94% 的醫療機構管理者預計將推遲設備升級,以應對不斷上漲的營運成本和關稅相關成本。這種普遍推遲採購決策的做法直接限制了製造商將最尖端科技推向市場的能力。因此,儘管臨床對術中影像的需求不斷成長,但由於醫療機構面臨如何證明新系統商業價值的財務挑戰,市場擴張潛力仍然有限。
將人工智慧 (AI) 應用於即時影像最佳化和分析,以解決輻射安全和營運效率問題,正在從根本上改變市場格局。 AI 演算法被整合到移動式 C 型臂系統中,可自動定位患者並提高影像清晰度,從而降低累積輻射劑量並縮短手術時間。這種向智慧化生產力的轉變,為專注於自動化工作流程技術以提高盈利的製造商帶來了經濟效益。根據 GE 醫療於 2024 年 10 月發布的“2024 會計年度第三季度財務業績”,其影像事業部的息稅前利潤 (EBIT) 較上年同期成長了 18%。這項成功歸功於透過先進的自動化功能來提高生產力的努力。
同時,移動影像技術與手術機器人導航系統的融合,正將C型臂的臨床應用從基礎診斷拓展至高階術中導航。為了滿足神經外科和脊椎外科手術所需的高精度要求,移動式C型臂的設計旨在與機器人平台無縫協作,從而建立一個用於植入放置和器械追蹤的整合生態系統。近期財務表現也印證了市場對這類整合技術的需求。例如,史賽克公司於2024年10月發布的「2024年第三季財報電話會議記錄」顯示,其醫療外科和神經技術部門的外匯匯率收入成長了12.9%,這表明將可視化技術與手術導引相結合的系統正被迅速採用。
The Global Mobile C-Arm Market is projected to expand from USD 1.98 Billion in 2025 to USD 2.75 Billion by 2031, registering a CAGR of 5.63%. These versatile diagnostic imaging units are essential in operating rooms for providing real-time fluoroscopic visualization during cardiovascular, orthopedic, and trauma surgeries. Growth is primarily fuelled by the increasing global burden of chronic diseases and an aging population necessitating surgical care, alongside a significant transition toward minimally invasive procedures that require intraoperative guidance. This demand is illustrated by NHS England data from 2024, which showed diagnostic imaging activity hitting 47.2 million tests-a 4.8% annual rise-while fluoroscopy specifically increased by 2.0%, highlighting the critical need for mobile imaging to improve surgical accuracy and patient results.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.98 Billion |
| Market Size 2031 | USD 2.75 Billion |
| CAGR 2026-2031 | 5.63% |
| Fastest Growing Segment | Flat Panel |
| Largest Market | North America |
Conversely, market growth faces substantial hurdles due to the high capital investment needed for these sophisticated systems and the strict budget limitations within healthcare facilities. Elevated costs for acquisition and maintenance often force smaller institutions to postpone equipment updates, thereby limiting the uptake of modern technologies. Additionally, the durability of existing hardware results in a prolonged replacement cycle that hinders rapid market penetration, creating a challenge for manufacturers to prove the return on investment for high-end mobile C-arm models despite their obvious clinical importance.
Market Driver
The escalating incidence of chronic ailments and orthopedic disorders serves as a major driver for the Global Mobile C-Arm Market. With the geriatric demographic growing, age-associated conditions like osteoporosis and osteoarthritis are leading to a higher volume of surgical procedures, specifically fracture repairs and joint replacements. Mobile C-arms are essential for these operations, providing high-resolution, real-time imaging that facilitates precise implant positioning and lowers revision rates. This upward trend is evidenced by the American Joint Replacement Registry's '2025 Annual Report' from October 2025, which noted that cumulative hip and knee arthroplasty procedures exceeded 4.4 million, marking an 8.8% rise from the prior year and underscoring the increased reliance on mobile imaging to handle the musculoskeletal disease burden.
Simultaneously, the rising global preference for minimally invasive surgical (MIS) techniques is transforming market dynamics. Medical providers are increasingly favoring methods that reduce patient trauma and speed up recovery, which depend heavily on the advanced fluoroscopic guidance offered by mobile C-arms, especially in spinal and cardiovascular interventions where accuracy is critical. This strong demand for interventional tools is reflected in Siemens Healthineers' 'Q4 Fiscal Year 2025 Earnings Release' from November 2025, where the Advanced Therapies segment achieved a 3.8% year-over-year revenue growth. Furthermore, market momentum is supported by ongoing medical infrastructure investments, as seen in GE HealthCare's October 2025 report showing a 6% total revenue increase in the third quarter driven by imaging performance, suggesting a continued growth trend as facilities enhance their diagnostic capacities for complex workflows.
Market Challenge
The Global Mobile C-Arm Market faces a significant obstacle in the form of substantial capital requirements for advanced imaging units, exacerbated by tight budgetary limits within healthcare organizations. Outpatient centers and hospitals often function with slim financial margins, compelling administrators to carefully evaluate every capital expense. The high costs associated with acquiring and maintaining equipment discourage facilities from replacing older units, resulting in the extended use of legacy hardware. This financial prudence interrupts the standard replacement cycle and creates a bottleneck for market growth, as a lack of funding postpones the adoption of newer, clinically superior mobile C-arm systems needed for complex procedures.
This pattern of delayed investment is confirmed by recent industry statistics illustrating the gravity of financial strain. Data from the American Hospital Association in 2025 indicates that approximately 94% of healthcare administrators anticipated postponing equipment upgrades to cope with rising operational expenses and tariff-related costs. Such widespread deferral of purchasing decisions directly restricts manufacturers from introducing premium technologies to the market. Consequently, even with growing clinical demand for intraoperative imaging, the market's expansion potential remains limited by the economic challenges healthcare providers face in justifying the return on investment for new systems.
Market Trends
The incorporation of Artificial Intelligence for Real-Time Image Optimization and Analytics is fundamentally transforming the market by tackling issues of radiation safety and operational efficiency. AI algorithms are being embedded into mobile C-arm systems to automate patient positioning and improve image sharpness, which decreases both cumulative dose exposure and procedure duration. This evolution toward intelligent productivity offers financial benefits for manufacturers focusing on automated workflow technologies to boost profitability. As reported by GE HealthCare in their 'Third Quarter 2024 Financial Results' from October 2024, the Imaging segment achieved an 18% year-over-year rise in segment EBIT, a success credited to robust productivity efforts utilizing these advanced automated features.
At the same time, the merging of Mobile Imaging with Surgical Robotics and Navigation Systems is broadening the clinical application of C-arms from basic diagnostics to sophisticated intraoperative guidance. With neurosurgery and spinal procedures requiring elevated precision, mobile C-arms are being designed to communicate seamlessly with robotic platforms, forming a unified ecosystem for implant placement and instrument tracking. The demand for such integrated technologies is highlighted by recent financial results; for instance, Stryker's 'Q3 2024 Earnings Call Transcript' from October 2024 revealed that the MedSurg and Neurotechnology segment posted constant currency sales growth of 12.9%, demonstrating the fast-paced adoption of systems that combine visualization with surgical navigation.
Report Scope
In this report, the Global Mobile C-Arm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Mobile C-Arm Market.
Global Mobile C-Arm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: